Table 3.
Therapeutic agents delivered with MB+FUS in animal models.
| Delivered agent | Proposed application | References |
|---|---|---|
| Adeno-associated virus | Gene therapy | 108-112,14 |
| Anti-Aβ | Alzheimer's disease | 96,98,99 |
| BCNU | Chemotherapeutic | 114,115 |
| Boronphenylalanine | Chemotherapeutic | 116,104 |
| Doxorubicin | Chemotherapeutic | 100,117 |
| Epirubicin | Chemotherapeutic | 93 |
| GDNF | Parkinson's disease, TBI | 118,119 |
| Herceptin | Chemotherapeutic, metastatic breast cancer | 120 |
| Htt-siRNA | Huntington's disease | 121,122 |
| Methotrexate | Chemotherapeutic | 123 |
| Stem cells | Neuroregeneration | 124 |
| Temozolomide | Chemotherapeutic | 125 |